Extendicare

The business

Extendicare operates across the continuum of senior care in Canada: long-term care homes, home health care (one of the country's largest providers of publicly funded home care), and management/consulting services to third-party operators. It has increasingly shifted toward an asset-lighter, services-and-management model while partnering on real estate development.

Its long-term care and home care revenues are largely funded by provincial governments, giving relatively stable, volume-driven cash flows, while home health care has been a notable growth engine as provinces expand community-based care to relieve hospital and institutional pressure.

The company has been redeveloping older long-term care homes into modern facilities, often through joint ventures that reduce its direct capital outlay, and continues to grow its management platform serving other operators.

The moat

One of the largest scaled platforms in Canadian long-term and home health care, a regulated business with high barriers to entry

Diversified across long-term care, home care and management services, reducing reliance on any single line

Government-funded revenue base provides defensiveness and visibility

Financial snapshot

Most recent reported period : Q1 2026 (reported May 8, 2026). Figures reflect the review date — confirm current numbers before acting.

Free cash flow yield & sustainable growth

Free cash flow yield : ≈4% (est.)Trailing P/E ~25x implies ~4% earnings yield; dividend yield only ~1.5% as payout is modest relative to earnings

Cash flow is underpinned by government-funded long-term care and home care volumes, with home health care providing the strongest organic growth as provinces expand community care.

The shift toward management and services plus JV-funded redevelopment lowers capital intensity and can lift returns on capital, though margins remain sensitive to labour availability and funding formulas.

See the full free-cash-flow yield ranking →

Valuation & what to watch

Extendicare trades at a mid-20s trailing P/E after a very strong run, reflecting the market's growing appreciation for its home-care growth and asset-light pivot. Earnings have grown briskly, so the forward multiple is meaningfully lower than trailing.

The valuation is no longer cheap; it prices in continued momentum in home health care and successful execution of the redevelopment pipeline. The low dividend yield signals a stock now valued more for growth than income.

Dividend

Pays a modest dividend yielding roughly 1.5%, a small payout relative to earnings.

Risks & the bear case

• Heavy dependence on provincial government funding levels and policy for long-term and home care
• Chronic care-staffing shortages and wage inflation pressure margins
• Shares have re-rated sharply, leaving less margin of safety if growth slows
• Redevelopment and JV execution risk in a tight construction/financing market

Recent developments

As of 2026-08-05, this profile reflects Extendicare's Q1 2026 (reported May 8, 2026); consult the company's latest filings and the linked sources for any developments since.

Verdict

A well-run, defensively funded senior-care and home-health platform enjoying strong home-care growth, but a big re-rating and a thin dividend mean much of the good news is priced in. Constructive on the business, cautious on the entry multiple. Moderate conviction.